Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Bio-Path Holdings Inc. (BPTH)

5.83   -0.4 (-6.42%) 02-25 16:00
Open: 6.2 Pre. Close: 6.23
High: 6.2878 Low: 5.67
Volume: 104,437 Market Cap: 22M
Bio-Path Holdings Inc is a clinical & preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.297 - 6.348 6.348 - 6.383
Low: 5.572 - 5.624 5.624 - 5.659
Close: 5.76 - 5.843 5.843 - 5.898

Technical analysis

as of: 2020-02-25 4:27:47 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 8.00     One year: 8.85
Support: Support1: 5.67    Support2: 4.72
Resistance: Resistance1: 6.85    Resistance2: 7.58
Pivot: 6.41
Moving Average: MA(5): 6.27     MA(20): 6.45
MA(100): 8.47     MA(250): 12.44
MACD: MACD(12,26): -0.27     Signal(9): -0.27
Stochastic oscillator: %K(14,3): 14.26     %D(3): 20.01
RSI: RSI(14): 33.06
52-week: High: 73.52  Low: 1.98  Change(%): 188.6
Average Vol(K): 3-Month: 12130  10-Days: 8160

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BPTH has closed below the lower band by 11.4%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 61.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to BPTH's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Bio-Path Holdings Completes Safety Testing Study in Stage 2 of Phase 2 Trial
The company announced it has completed the safety testing in the second stage of its Phase 2 clinical trial in acute myeloid leukemia. The post Bio-Path Holdings Completes Safety Testing Study in Stage 2 of Phase 2 Trial appeared first on Investing News Network .

Bio-Path’s Shares Dip on IND Application Approval
The FDA has approved Bio-Path's IND for its second drug candidate, but the news sent the company's shares down over 30 percent. The post Bio-Path’s Shares Dip on IND Application Approval appeared first on Investing News Network .

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 3.69
Shares Float (M) 2.53
% Held by Insiders 5.29
% Held by Institutions 29.11
Shares Short (K) 133
Shares Short P. Month (K)

Stock Financials

EPS -4.010
Book Value (p.s.) 5.560
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -44.0
Return on Equity (ttm) -85.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.995
Qtrly Earnings Growth
Operating Cash Flow (M) -7.40
Levered Free Cash Flow (M) -4.56

Stock Valuations

P/E -1.45
P/E Growth Ratio -0.06
P/BV 1.05
P/CF -2.91

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-01-17
Last Split Ratio 0.05
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.